Delivery Order SPE2DB22D2007-SPE2DB24FJ5YR

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The $5,342.92 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024. The contract has an ultimate completion date of December 20, 2024 and is not designated with any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,542.09 firm fixed-price delivery order has a completion date of September 12, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,125.04 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024, with a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4565892104 ONDANSETRON ODT 4 MG TABLET 30S to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $29,366.71 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on September 20, 2024, with a completion date of September 23, 2024. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 4562586704 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,165.84 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of October 25, 2023 and was awarded on October 24, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $13,759.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4566412425 - ONDANSETRON ODT 4 MG TABLET 30S, a generic pharmaceutical product. This...
This federal contract award is for the delivery of ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $4,000.89, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on August 28, 2024, with a completion date of August 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,423.32 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 23, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The $1,732.57 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 18, 2024, with a completion date of July 19, 2024. This appears to be a delivery order against an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $3,661.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for 4568143819 - ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of May 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ5YR
    Delivery Order

This federal contract award is for the delivery of ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The $3,631.11 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor supplying medical products to government agencies.

The award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. Amerisourcebergen also holds another notable IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. This contract award does not have a set-aside designation.

Generated 12/10/24, 2:31 PM